Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Janneke Wilschut"'
Autor:
Ranjit Manchanda, Li Sun, Shreeya Patel, Olivia Evans, Janneke Wilschut, Ana Carolina De Freitas Lopes, Faiza Gaba, Adam Brentnall, Stephen Duffy, Bin Cui, Patricia Coelho De Soarez, Zakir Husain, John Hopper, Zia Sadique, Asima Mukhopadhyay, Li Yang, Johannes Berkhof, Rosa Legood
Publikováno v:
Cancers, Vol 12, Iss 7, p 1929 (2020)
Clinical criteria/Family history-based BRCA testing misses a large proportion of BRCA carriers who can benefit from screening/prevention. We estimate the cost-effectiveness of population-based BRCA testing in general population women across different
Externí odkaz:
https://doaj.org/article/8abf9ef457f243079f3da10713298439
Autor:
Karlijn J. Nass, Janneke Wilschut, Michel W.J.M. Wouters, Crispijn L. van den Brand, Paul Fockens, Evelien Dekker, Manon van der Vlugt, Arthur K.E. Elfrink
Publikováno v:
Endoscopy, 54(5), 455-462. Georg Thieme Verlag
Endoscopy. GEORG THIEME VERLAG KG
Endoscopy
Endoscopy. Georg Thieme Verlag
Endoscopy. GEORG THIEME VERLAG KG
Endoscopy
Endoscopy. Georg Thieme Verlag
Background Nonmodifiable patient and endoscopy characteristics might influence colonoscopy performance. Differences in these so-called case-mix factors are likely to exist between endoscopy centers. This study aimed to examine the importance of case-
Autor:
Rob J. Ouwendijk, A. van der Beek, Aura A. J. van Esch, Janneke Wilschut, Thalia Hummel, Arthur K.E. Elfrink, Peter J. van der Schaar, Manon van der Vlugt, Manon C.W. Spaander, Michiel Ledeboer, Monique E. van Leerdam, J. Nass, Evelien Dekker, Marc A. Verhagen, C.L. van den Brand, Paul Fockens, Michel W.J.M. Wouters
Publikováno v:
Gastrointestinal Endoscopy. 93:AB14-AB15
Autor:
Monique E. van Leerdam, Janneke Wilschut, Iris Lansdorp-Vogelaar, J. Dik F. Habbema, Marjolein van Ballegooijen, Ewout W. Steyerberg
Publikováno v:
Cancer, 117(18), 4166-74. John Wiley and Sons Inc.
Wilschut, J A, Steyerberg, E W, van Leerdam, M E, Lansdorp-Vogelaar, I, Habbema, J D F & van Ballegooijen, M 2011, ' How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer? ', Cancer, vol. 117, no. 18, pp. 4166-74 . https://doi.org/10.1002/cncr.26009
Cancer, 117(18), 4166-4174. John Wiley & Sons Inc.
Wilschut, J A, Steyerberg, E W, van Leerdam, M E, Lansdorp-Vogelaar, I, Habbema, J D F & van Ballegooijen, M 2011, ' How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer? ', Cancer, vol. 117, no. 18, pp. 4166-74 . https://doi.org/10.1002/cncr.26009
Cancer, 117(18), 4166-4174. John Wiley & Sons Inc.
BACKGROUND: Individuals with a family history of colorectal cancer (CRC) are at increased risk for CRC. Current screening recommendations for these individuals are based on expert opinion. The authors investigated optimal screening strategies for ind
Autor:
Janneke Wilschut, Marjolein van Ballegooijen, Ann G. Zauber, Iris Lansdorp-Vogelaar, Karen M. Kuntz, Amy B. Knudsen
Publikováno v:
Lansdorp-Vogelaar, I, Kuntz, K M, Knudsen, A B, Wilschut, J A, Zauber, A G & van Ballegooijen, M 2010, ' Stool DNA testing to screen for colorectal cancer in the Medicare population : a cost-effectiveness analysis ', Annals of Internal Medicine, vol. 153, no. 6, pp. 368-77 . https://doi.org/10.7326/0003-4819-153-6-201009210-00004
Annals of Internal Medicine, 153(6), 368-W124. American College of Physicians
Annals of Internal Medicine, 153(6), 368-77. American College of Physicians
Annals of Internal Medicine, 153(6), 368-W124. American College of Physicians
Annals of Internal Medicine, 153(6), 368-77. American College of Physicians
BACKGROUND: The Centers for Medicare & Medicaid Services considered whether to reimburse stool DNA testing for colorectal cancer screening among Medicare enrollees.OBJECTIVE: To evaluate the conditions under which stool DNA testing could be cost-effe
Publikováno v:
American Journal of Gastroenterology, 105(8), 1861-1869. Springer Nature
Ramsey, S D, Wilschut, J, Boer, R & van Ballegooijen, M 2010, ' A Decision-Analytic Evaluation of the Cost-Effectiveness of Family History-Based Colorectal Cancer Screening Programs ', American Journal of Gastroenterology, vol. 105, no. 8, pp. 1861-1869 . https://doi.org/10.1038/ajg.2010.185
Ramsey, S D, Wilschut, J, Boer, R & van Ballegooijen, M 2010, ' A Decision-Analytic Evaluation of the Cost-Effectiveness of Family History-Based Colorectal Cancer Screening Programs ', American Journal of Gastroenterology, vol. 105, no. 8, pp. 1861-1869 . https://doi.org/10.1038/ajg.2010.185
OBJECTIVES: The aim of this study was to determine the cost-effectiveness of family history screening (FHS) for colorectal cancer (CRC) susceptibility at age 40 with early screening of those with increased risk. METHODS: The cost-effectiveness of sev
Autor:
Rob J. de Boer, Janneke Wilschut, Ann G. Zauber, J. Dik F. Habbema, Iris Lansdorp-Vogelaar, Marjolein van Ballegooijen
Publikováno v:
International Journal of Cancer, 124(5), 1161-1168. Wiley-Liss Inc.
The costs of computed tomographic colonography (CTC) are not yet established for screening use. In our study, we estimated the threshold costs for which CTC screening would be a cost-effective alternative to colonoscopy for colorectal cancer (CRC) sc
Autor:
Sidney J. Winawer, Janneke Wilschut, Ann G. Zauber, Iris Lansdorp-Vogelaar, Marjolein van Ballegooijen, Rob Boer, J. Dik F. Habbema
Publikováno v:
Gastrointestinal Endoscopy, 70(1), 96-108. Mosby Inc.
Background: There is increasing discussion whether colorectal cancer (CRC) screening guidelines should be individualized by sex and race. Objectives: To determine individualized colonoscopic screening guidelines by sex and race for the average-risk p
Autor:
Janneke Wilschut, J. Dik F. Habbema, Lieke Hol, Monique E. van Leerdam, Ernst J. Kuipers, Iris Lansdorp-Vogelaar, Marjolein van Ballegooijen
Publikováno v:
Journal of the National Cancer Institute, 103(23), 1741-51. Oxford University Press
Wilschut, J A, Habbema, J D F, van Leerdam, M E, Hol, L, Lansdorp-Vogelaar, I, Kuipers, E J & van Ballegooijen, M 2011, ' Fecal occult blood testing when colonoscopy capacity is limited ', Journal of the National Cancer Institute, vol. 103, no. 23, pp. 1741-51 . https://doi.org/10.1093/jnci/djr385
Journal of the National Cancer Institute, 103(23), 1741-1751. Oxford University Press
Wilschut, J A, Habbema, J D F, van Leerdam, M E, Hol, L, Lansdorp-Vogelaar, I, Kuipers, E J & van Ballegooijen, M 2011, ' Fecal occult blood testing when colonoscopy capacity is limited ', Journal of the National Cancer Institute, vol. 103, no. 23, pp. 1741-51 . https://doi.org/10.1093/jnci/djr385
Journal of the National Cancer Institute, 103(23), 1741-1751. Oxford University Press
BACKGROUND: Fecal occult blood testing (FOBT) can be adapted to a limited colonoscopy capacity by narrowing the age range or extending the screening interval, by using a more specific test or hemoglobin cutoff level for referral to colonoscopy, and b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12b072b47b718f65134d4b5b65c63a13
https://research.vumc.nl/en/publications/38362bcc-520a-4a6e-9417-007ee9414d7c
https://research.vumc.nl/en/publications/38362bcc-520a-4a6e-9417-007ee9414d7c
Autor:
Lieke Hol, Ernst J. Kuipers, Dik J.F. Habbema, Alexandra C M van der Togt, Katharina Biermann, Marjolein van Ballegooijen, Jacqueline C. Reijerink, Jan Francke, Monique E. van Leerdam, Anneke J van Vuuren, Hans 't Mannetje, Janneke Wilschut, Laura J.C. Kranenburg, Aafke H. van Roon
Publikováno v:
Clinical Gastroenterology and Hepatology, 9(4), 333-9. W.B. Saunders Ltd
Clinical Gastroenterology and Hepatology, 9(4), 333-339. W.B. Saunders
van Roon, A H C, Wilschut, J A, Hol, L, van Ballegooijen, M, Reijerink, J C I Y, 't Mannetje, H, Kranenburg, L J C, Biermann, K, van Vuuren, A J, Francke, J, van der Togt, A C M, Habbema, D J F, van Leerdam, M E & Kuipers, E J 2011, ' Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance ', Clinical Gastroenterology and Hepatology, vol. 9, no. 4, pp. 333-9 . https://doi.org/10.1016/j.cgh.2010.12.012
Clinical Gastroenterology and Hepatology, 9(4), 333-339. W.B. Saunders
van Roon, A H C, Wilschut, J A, Hol, L, van Ballegooijen, M, Reijerink, J C I Y, 't Mannetje, H, Kranenburg, L J C, Biermann, K, van Vuuren, A J, Francke, J, van der Togt, A C M, Habbema, D J F, van Leerdam, M E & Kuipers, E J 2011, ' Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance ', Clinical Gastroenterology and Hepatology, vol. 9, no. 4, pp. 333-9 . https://doi.org/10.1016/j.cgh.2010.12.012
BACKGROUND & AIMS: The fecal immunochemical test (FIT) is superior to the guaiac-based fecal occult blood test in detecting neoplasia. There are not much data on the optimal number of FITs to perform. We conducted a population-based trial to determin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::566bf8273f567054b9a80ca2334c3eca
https://research.vumc.nl/en/publications/ed598ea2-5df5-4331-b57a-b1b9de2152ec
https://research.vumc.nl/en/publications/ed598ea2-5df5-4331-b57a-b1b9de2152ec